Government of Canada invests in scientific and clinical hub for orphan drug developments

Researchers Seek New Drug Treatments for Rare Diseases September 13, 2016 - Halifax, N.S. – Atlantic Canada Opportunities Agency (ACOA) Rare diseases, as the name suggests, have small patient populations. Historically, these were “orphaned” by the pharmaceutical industry— leaving few approved drug treatment options for those with these “orphan diseases.” An innovative project underway at Dalhousie University is looking to change this, and the project is receiving an investment of $3,000,000 from the Government of Canada to position the province as a hub of research and development in this field. This investment, provided through ACOA’s Atlantic Innovation Fund, was announced today by Andy Fi



Sep 25, 2019

Location: Halifax, Nova Scotia

CGEM Seminar Series

Dr. Jeffrey Medin will be giving a talk on Wednesday September 25th as part of the CGEM Seminar Series. The talk will take place in the LSRI McNamara Boardroom at 12 noon and will be titled 'Lentivirus-Mediated Gene Therapy for Fabry Disease'. To be included on the invitation email list please email

Sep 13, 2016

Location: Life Sciences Research Institute

ACOA Announces $3M Aimed at Finding New Treatments for Rare Diseases

AIF Press Announcement

Location: Halifax, Nova Scotia, Canada

CGEM Official Launch

Further details on Date & Times TBA


Please reload

Follow Us
  • Blogger Social Icon
  • Twitter Social Icon
  • Facebook Social Icon
  • LinkedIn Social Icon